<DOC>
	<DOCNO>NCT01641315</DOCNO>
	<brief_summary>Reduced 4-dose intramuscular rabies vaccination schedule announce US-ACIP WHO one post-exposure prophylaxis regimen . However , concurrent usage regimen rabies immunoglobulin never study aspect immunity level would protective level require WHO ( 0.5 IU/ml ) least year period . This study would access subject .</brief_summary>
	<brief_title>Immunogenicity Study Reduced ( 4-dose ) Vaccine Schedule Rabies Immunoglobulins</brief_title>
	<detailed_description>- Controlled trial study - All 75 volunteer never rabies immunization would enrol designated 3 group . group 1 : 25 Healthy volunteer age 18 - 60 yr attack mammal , possible expose rabies WHO category III exposure , receive standard post - exposure rabies treatment 5-dose intramuscular rabies vaccine day 0,3,7,14,28 40 IU/kg equine rabies immune globulin ( ERIG ) . group 2 : 25 Healthy volunteer age 18 - 60 yr receive 4-dose intramuscular rabies vaccine day 0,3,7,14 40 IU/kg equine rabies immune globulin ( ERIG ) . group 3 : 25 Healthy volunteer age 18 - 60 yr receive 4-dose intramuscular rabies vaccine day 0,3,7,28 40 IU/kg equine rabies immune globulin ( ERIG ) . 5 cc - Blood would draw volunteer vaccination day 14 , 28 , 90 360 rabies neutralize antibody titer ( RNab ) . The GMTs RNab among group would analyze compare .</detailed_description>
	<mesh_term>Rabies</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Immunoglobulins</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<criteria>healthy volunteer age 1860 year . receive prior rabies immunization pregnancy immunocompromised condition</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>rabies</keyword>
	<keyword>rabies immunoglobulin</keyword>
</DOC>